28 results about "Chest ache" patented technology

The invention discloses an acute myocardial infarction diagnosis method based on interpretable hybrid ensemble learning. The specific implementation process is as follows: performing data preprocessing on collected original chest pain data; the adaptability of a single basic algorithm is enhanced through nested iterative optimization and global hyper-parameter tuning; dynamic multi-strategy integration is utilized to select an optimal integration strategy, and layered feature abstraction, probability calibration fusion and a consensus decision mechanism are included; in order to improve clinical transparency, a game theory marginal contribution analysis framework is constructed, and SHAP values of global and local feature contributions are quantified; collaboratively optimizing data-driven feature dimension reduction and clinical knowledge verification on the basis of SHAP value ranking, screening out six key clinical features, and constructing a hybrid integrated learning model; the method is further used for STEMI, NSTEMI and non-AMI diagnosis, and the complex diagnosis adaptability of the method is verified. According to the method, algorithm diversity and clinical transparency are integrated, and effective acute myocardial infarction diagnosis is realized.

The invention belongs to the field of biological detection, and particularly relates to application of an ON detection reagent in auxiliary diagnosis of acute chest pain diseases. It is found that the ON protein is closely related to acute chest pain such as AAD, AMI and APE, the ON serves as a marker, a detection reagent of the ON is prepared into an auxiliary diagnosis product, and great clinical value and practical significance are achieved for early diagnosis and long-term prognosis of the three diseases (especially AAD) and improvement of life quality.

The invention discloses a multi-modal and large-model quality control system based on multi-center data of chest pain, stroke and trauma. The quality control system comprises the following steps: collecting and preprocessing multi-modal data of three major centers of chest pain, stroke and trauma; for different types of quality control multi-modal data of the three major centers, performing feature extraction and feature alignment on the different types of quality control multi-modal data by using a multi-modal data encoder; according to cross-modal self-attention in a multi-modal data encoder, carrying out multi-modal feature fusion on the aligned multi-modal features; uniformly mapping and modeling the fused feature vectors to generate a quality control comprehensive model of the three major centers, and outputting quality control indexes and abnormal points of the three major centers through the quality control comprehensive model; and performing multi-dimensional display comparison on an output result of the quality control comprehensive model. According to the invention, quality control data of three major centers of chest pain, stroke and trauma are fused and subjected to modeling analysis, so that the quality control management is more accurate and efficient.

As a common complication, hydrothorax and ascites are poor in prognosis in a clinical intervention mode mainly based on symptomatic treatment. Under the guidance of a new theory of'inflammation-cancer 'transformation, the invention discloses a traditional Chinese medicine composition for preventing and treating hydrothorax and ascites and a preparation method for oral administration and external application. The composition comprises the following traditional Chinese medicinal materials in parts by mass: 3-20 parts of codonopsis pilosula, 3-20 parts of raw bighead atractylodes rhizome, 3-18 parts of cassia twig, 3-18 parts of radices trichosanthis, 3-12 parts of pseudo-ginseng, 3-15 parts of Chinese lobelia, 3-15 parts of bistort rhizome, 3-15 parts of euphorbia helioscopia and 3-15 parts of semen lepidii. The traditional Chinese medicine composition disclosed by the invention has the effects of strengthening the body resistance, dispersing blood stasis, detoxifying, clearing damp, inducing diuresis and diminishing swelling, and has good effects on preventing and treating inflammatory hydrothorax and ascites and malignant hydrothorax and ascites as well as dyspnea, chest pain, cough, anorexia, abdominal pain, abdominal distension, weakness, night sweat and the like caused by the inflammatory hydrothorax and ascites and the malignant hydrothorax and ascites. The preparation method comprises decoction, granules, pills, capsules and powder. The traditional Chinese medicine composition is helpful for promoting absorption and discharge of hydrothorax and ascites, diminishing inflammation and resisting cancer, adjusting and recovering physiological functions of internal organs, and improving life quality of patients.

The health-preserving conditioning tea is prepared from the following raw materials in parts by weight: 3 to 8g of earthworms, 2 to 9g of flos carthami, 4 to 7g of ground beetles, 5 to 10g of leeches, 1.5 to 6g of radix aucklandiae, 3 to 8g of herba verbenae, 2 to 5g of gadflies, 3 to 7g of arisaema cum bile, 6 to 10g of radix salviae miltiorrhizae, 4 to 8g of radix paeoniae rubra, 2 to 6g of bombyx batryticatus, 1.5 to 5g of scorpions and 4 to 9g of folium ginkgo. The conditioning tea has the beneficial effects that the conditioning tea not only can replace traditional western medicines and avoid drug resistance and side effects, but also is convenient to carry and take after being bagged, can relieve and reduce the symptoms of cardiovascular and cerebrovascular plaques, namely blockage, during long-term taking according to the treatment course, can prevent cardiovascular and cerebrovascular diseases, activate blood and promote menstruation, and can be used for treating cardiovascular and cerebrovascular diseases. The traditional Chinese medicine composition has the effects of tonifying qi, preserving health, reducing blood fat and blood pressure, and also can be used for treating diseases such as chest distress, chest pain, cardiac hypertrophy, mitral valve and tricuspid valve regurgitation, myocardial ischemia and the like.

The invention discloses a time axis key node automatic acquisition system for chest pain diagnosis and treatment, and relates to the technical field of information and communication of medical data, and the time axis key node automatic acquisition system comprises the following steps: pre-storing an interval template containing a starting or ending anchor point rule; acquiring an event stream which comes from one or more medical information systems and carries a chest pain patient identifier and a source system timestamp in real time; creating and maintaining an active interval instance in a memory for the chest pain patient; inferring a candidate end event; and identifying the time reference drift of the source system, and adding a credibility mark to the time-consuming data. Automatic and real-time monitoring of time consumption in the diagnosis and treatment process is achieved, the system supports starting and ending anchor point matching, automatically recognizes time reference drift and adds credibility marks, and the reliability of time consumption data in a real and complex environment is guaranteed on the premise of not depending on strict time synchronization of a hospital-wide system.

The invention belongs to the technical field of cardiovascular disease treatment medicines, and particularly relates to a traditional Chinese medicine composition for qi deficiency, blood stasis and phlegm stagnation type coronary heart disease as well as a preparation method and application thereof. The traditional Chinese medicine composition comprises codonopsis pilosula, astragalus membranaceus, dogwood, rhizoma anemarrhenae, platycodon grandiflorum, radix bupleuri, rhizoma cimicifugae, rhizoma sparganii, curcuma zedoary, cassia twig, trichosanthes kirilowii maxim, allium macrostemon, rhizoma pinelliae preparata, Chinese yam and honey-fried licorice root. The traditional Chinese medicine composition can tonify qi, activate blood, eliminate phlegm and resolve turbidity, can be used for treating qi deficiency, blood stasis and phlegm stagnation type coronary heart disease, and can treat both symptoms and root causes. Experiments prove that for a mouse with coronary heart disease, the traditional Chinese medicine composition can obviously improve the heart function of the mouse, and has the effects of inhibiting atherosclerosis and regulating lipid metabolism; for patients with qi deficiency, blood stasis and phlegm stagnation type coronary heart disease, the traditional Chinese medicine composition can improve the symptoms of chest pain and chest distress of the patients. Therefore, the traditional Chinese medicine composition can be used for preparing a medicine for treating qi deficiency, blood stasis and phlegm stagnation type coronary heart disease, and can also be used for preparing a medicine for regulating blood fat.

The present application relates to the technical field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for treating postoperative discomfort of lung cancer and / or reducing lung nodules and application thereof. The traditional Chinese medicine composition is prepared according to the theory of traditional Chinese medicine, and the prescription aims to regulate the lung, supplement qi, resolve phlegm and remove stasis, remove pathogenic factors in the lung, and restore the descending function of the lung. The traditional Chinese medicine composition can be used in the postoperative stage of lung cancer, especially the postoperative stage of non-small cell lung cancer, to improve postoperative symptoms such as cough, expectoration, chest pain and fatigue. The traditional Chinese medicine composition has mild drug properties and high safety. The traditional Chinese medicine composition comprises 15 kinds of traditional Chinese medicines, the legal standard sources of the medicinal properties are clear, no medicinal materials with toxicity or modern toxicological evidence of toxicity are contained, there is no compatibility taboo of eighteen incompatibilities and nineteen incompatibilities, and the dosages of the medicinal properties are within the standard range.

The traditional Chinese medicine composition is characterized by being prepared from the following traditional Chinese medicinal materials in parts by weight: 3 to 9 parts of rhizoma chuanxiong, 3 to 7 parts of rhizoma atractylodis, 6 to 14 parts of rhizoma cyperi, 6 to 14 parts of medicated leaven, 3 to 7 parts of euphorbia helioscopia, 10 to 20 parts of poria cocos, 8 to 12 parts of fructus trichosanthis, 8 to 12 parts of radix salviae miltiorrhizae, 8 to 12 parts of herba epimedii, 3 to 9 parts of pepper, 8 to 12 parts of herba patriniae and 8 to 12 parts of caulis spatholobi. After the traditional Chinese medicine composition is used for treating acute myocardial infarction, a remarkable effect is achieved on PCI postoperative improvement of acute myocardial infarction, troponin and creatine kinase isoenzyme indexes are reduced, and the left ventricular ejection fraction is in a normal range after cardiac color ultrasound display treatment. Through comprehensive conditioning, symptoms such as chest distress, chest pain, shortness of breath and hypodynamia of patients are improved, cardiac function recovery is promoted, complications such as restenosis and heart failure are prevented, and life quality is improved.

The present invention discloses the use of a traditional Chinese medicine compound composition in preparing a drug for treating chest pain after coronary heart disease stent implantation, belonging to the technical field of traditional Chinese medicine. The traditional Chinese medicine compound composition comprises, by weight, 9-60 parts of peach kernel, 6-50 parts of safflower, 10-60 parts of gardenia, 15-90 parts of salvia miltiorrhiza, 10-60 parts of cyperus rotundus, 15-90 parts of millettia reticulata, 15-90 parts of angelica sinensis, 8-50 parts of ligusticum chuanxiong, 15-90 parts of red peony root, and 15-90 parts of codonopsis pilosula. The main components of the Chinese patent medicine include the volatile oil, alcohol extract, water extract and pharmaceutically acceptable excipients of the above-mentioned Chinese medicine compound composition, wherein the volatile oil is the volatile oil extracted from the Chinese medicine compound composition by steam distillation; the alcohol extract is the extract obtained by extracting the volatile oil from the Chinese medicine compound composition by steam distillation and then subjecting it to alcohol extraction treatment; the water extract is the extract obtained by extracting the volatile oil from the Chinese medicine compound composition by steam distillation and alcohol extraction treatment and then subjecting it to water extraction treatment.

The invention discloses firewood-raisin tree bark and pinellia ternate granules as well as a preparation method and application thereof, and relates to the technical field of traditional Chinese medicines. The granules are prepared from seven traditional Chinese medicinal materials including radix bupleuri, radix scutellariae, fructus aurantii, ginger processed pinellia, pericarpium trichosanthis, radix paeoniae rubra and platycodon grandiflorum according to a specific weight ratio, and through a synergistic effect, the effects of soothing the liver, regulating qi, clearing heat, reducing phlegm, relieving chest stuffiness and removing stasis are achieved. The preparation method mainly comprises the following steps: repeatedly decocting and extracting with water, merging filtrate, concentrating under reduced pressure to prepare clear paste, drying, adding a proper amount of diluent, adhesive and corrigent, granulating and sub-packaging. The preparation process is scientific and reasonable, has good reproducibility, is easy to realize standardized and industrial mass production, and can effectively ensure the stability and uniformity of batch-to-batch quality. The traditional Chinese medicine composition can effectively relieve symptoms such as chest pain, cough and dyspnea, promotes pleural effusion absorption, is safe in clinical application, and provides a new and effective traditional Chinese medicine choice for treatment of tuberculous pleurisy.

This invention relates to the field of intelligent diagnosis and treatment technology, and particularly to a precision diagnosis and treatment method and system for non-high-risk chest pain populations. The method includes: acquiring known clinical information, known coronary artery imaging information, and known long-term clinical events of non-high-risk chest pain populations to construct a dataset; training an XGBoost model using the dataset to obtain a risk prediction scoring model; acquiring clinical information of the non-high-risk chest pain patient to be tested, inputting it into the risk prediction scoring model to obtain a risk prediction score; determining the group to which the non-high-risk chest pain patient belongs based on the risk prediction score; and determining subsequent diagnosis and treatment strategies based on the group to which the non-high-risk chest pain patient belongs and the patient's clinical information. This invention can more accurately predict the risk of non-high-risk chest pain patients, and for low-risk non-high-risk chest pain patients, it can reduce unnecessary invasive examinations and achieve effective resource allocation.

The application discloses a composition of Qixuebengzhi recipe and belongs to the field of traditional Chinese medicines; the composition is mainly prepared from bupleurum, immature fruit of citrus, persicae semen, safflower, chuanxiong and red peony root; the application is based on the concept of treating heart and body simultaneously, and through the ascending and descending of qi and the regulating of liver qi of bupleurum and immature fruit of citrus, the composition can dredge the liver and regulate qi, and through the dispersing of persicae semen and safflower, the composition can dredge the channels and remove stasis, and through the combination of chuanxiong and red peony root, the composition can regulate qi and blood, and the combination of the medicines can directly attack the core pathogenesis of qi stagnation and blood stasis; clinical verification shows that the composition can not only significantly improve the TCM syndromes such as chest pain and chest distress of patients and the frequency of angina pectoris attacks, but also quickly relieve anxiety and depression and improve sleep quality.

The invention relates to application of a traditional Chinese medicine composition in preparation of a medicine for treating pulmonary nodules. The traditional Chinese medicine composition comprises the following raw materials in parts by weight: 20-30 parts of salted morinda officinalis; 20-30 parts of radix bupleuri; and 20-30 parts of chrysanthemum. Wherein the pulmonary nodules comprise one or two of ground glass pulmonary nodules and solid pulmonary nodules. The traditional Chinese medicine composition can effectively reduce pulmonary nodules and quickly improve or eliminate symptoms such as cough and chest pain caused by the pulmonary nodules.

The invention relates to the technical field of body conditioning medicines, in particular to a medicine formula for conditioning a circulation system in a body and a preparation process of the medicine formula. The invention relates to a medicine formula for conditioning in-vivo circulation system and a preparation process thereof, the medicine formula comprises a main material and an auxiliary material, and is characterized in that the main material is prepared by mixing the following raw materials by weight: 16-22g of salvia miltiorrhiza, 8-12g of astragalus membranaceus, 1-5g of pseudo-ginseng powder, 18-22g of fried spina date seed, 6-15g of ginseng, 6-12g of borneol, 18-24g of folium artemisiae argyi and 8-14g of borneol; the auxiliary material is prepared by mixing the following raw materials by weight: 10-20 g of poria cocos, 8-15 g of bighead atractylodes rhizome, 10-15 g of cassia twig, 20-25 g of dried ginger, 13-26 g of cornu cervi pantotrichum, 5-12 g of herba epimedii, 11-22 g of rhizoma polygonati, 18-28 g of codonopsis pilosula, 17-25 g of angelica sinensis and 15-30 g of chrysanthemum. The formula has the beneficial effects that the formula is scientific in preparation, balanced in nutrition and proper in proportion, has the effects of balancing yin and yang, coordinating internal organs, removing blood stasis and dissipating binds and the like, and can prevent and condition cardiovascular and cerebrovascular diseases, cerebral thrombosis, hypertension, coronary heart disease, heart failure, arrhythmia, rheumatic heart disease, palpitation, chest pain, headache, hemiplegia of half limbs, cerebral infarction and other diseases.

The invention belongs to the technical field of pharmaceutical compositions, and provides a traditional Chinese medicine composition for treating atherosclerosis and improving inflammatory response as well as a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition provided by the invention adopts radix bupleuri, radix paeoniae alba, fructus aurantii stir-fried with bran, angelica sinensis, peach kernels, safflower carthamus, ligusticum wallichii, radix rehmanniae, fructus gardeniae praeparatus, rhizoma atractylodis macrocephalae stir-fried with bran, poria cocos, leech, earthworm and honey-fried licorice root as main raw materials, can inhibit serum inflammation, reduce the blood fat level, improve the chronic inflammation state of an organism, stabilize atherosclerotic plaque and delay the pathological progress of the atherosclerotic plaque, and has a good application prospect. The traditional Chinese medicine composition can reduce acute cardiovascular and cerebrovascular accident risks, can relieve symptoms and signs of chest distress, chest pain, unsmooth emotion, uncomfortable hypochondrium, pale and dark tongue with ecchymosis and astringent pulse of patients with atherosclerosis and coronary heart disease, and improves life quality. In addition, the traditional Chinese medicine composition provided by the invention also has the characteristics of simplicity in preparation, low cost, safety, no toxic or side effect, convenience in carrying, convenience in taking and the like.

The utility model relates to the technical field of medical informatization equipment, in particular to a chest pain center informatization display device which comprises a fixing frame, a base frame and a display screen. A plurality of mounting holes are formed in the fixing frame, and the fixing frame is fixedly mounted on a wall surface through the mounting holes by means of expansion bolts; the fixing frame is further provided with a strip-shaped hole track. The base frame penetrates through the strip-shaped hole track through a fastening screw and is installed on the strip-shaped hole track in a screwed mode, a connecting shaft is fixed to the front face of the base frame, a bottom plate is fixed to the connecting shaft, and the display screen is installed on the bottom plate. According to the display device, flexible adjustment of the installation position is achieved through the strip-shaped hole track on the fixing frame and the base frame with the adjustable position, and the display device can meet the requirements for the positions of the display screen in different wall installation positions and different use scenes.

The present invention discloses a traditional Chinese medicine preparation for treating coronary atherosclerotic heart disease complicated with anxiety and depression. The preparation is prepared from the following raw materials: 25-35 g of processed Chuanwu, 8-12 g of black aconite root, 25-35 g of cinnamon twig, 25-35 g of bupleurum root, 25-35 g of turmeric root, 25-35 g of cyperus rotundus, 25-35 g of immature bitter orange, 25-35 g of atractylodes macrocephala, 45-55 g of raw dragon bone, 45-55 g of raw oyster, 25-35 g of raw betel nut, 25-35 g of toosendan fruit, and 25-35 g of green tangerine peel. Clinical studies have shown that the traditional Chinese medicine preparation of the present invention significantly improves symptoms such as chest tightness and pain, palpitations, shortness of breath, insomnia, anxiety, irritability, and depression in patients after treatment, compared with a control group (taking delexin orally). The improvement in SAQ scores, HAMD scores, HAMA scores, and TCM syndrome scores is also better than that of the control group, demonstrating significant efficacy.

The invention discloses a pharmaceutical composition for early intervention of malignant pulmonary nodules and a preparation method of the pharmaceutical composition. The pharmaceutical composition is prepared from 16 traditional Chinese medicines such as raw astragalus membranaceus and angelica sinensis through scientific compatibility. PI3K / AKT and TGF-beta / Smad signal channels are regulated and controlled through multiple targets, and the effects of tonifying qi, activating blood, reducing phlegm and resolving masses are achieved. Clinical studies show that the compound can significantly improve cough, short breath and chest pain symptoms (Plt; 0.05) of patients with qi stagnation and blood stasis syndromes, reduce GGO (ground glass sample) nodule metabolic activity (SUVmax decrease is greater than or equal to 40%), and effectively block malignant progression of pulmonary nodules. The preparation is mature in process and can be prepared into various dosage forms, and a safe and effective traditional Chinese and western medicine combined solution is provided for prevention and treatment of precancerous lesions of pulmonary nodules.

The application discloses a traditional Chinese medicine composition, preparation and application for treating coronary heart disease angina pectoris or post-PCI angina pectoris of the type of qi deficiency and blood stasis. The traditional Chinese medicine composition is composed of the following raw medicinal materials in weight: 30-40g of Astragalus membranaceus, 20-30g of Pueraria lobata, 10-15g of Rhodiola, 10-15g of Curcuma zedoary, 10-15g of Acorus gramineus Soland and 10-15g of Notopterygium. The application of the traditional Chinese medicine composition is used in the preparation of a medicine for treating coronary heart disease angina pectoris or post-PCI angina pectoris of the type of qi deficiency and blood stasis. The traditional Chinese medicine composition has the effects of treating both the root cause and symptoms and strengthening the body resistance and eliminating pathogenic factors on the coronary heart disease angina pectoris or post-PCI angina pectoris caused by qi deficiency and blood stasis, and can simultaneously supplement qi and raise yang, activate blood and remove stasis, and not forget to strengthen analgesia and warm and resolve cold phlegm, and give consideration to both the main and the secondary. The traditional Chinese medicine composition is well matched, can significantly improve the chest distress and chest pain symptoms of patients, and the total effective rate of the TCM syndrome curative effect reaches 90%.

The invention provides a processing method of pseudo-ginseng, a pseudo-ginseng processed finished product and application, and particularly belongs to the technical field of traditional Chinese medicine processing. The processing method of pseudo-ginseng comprises the following steps: mixing pseudo-ginseng with water to obtain a mixture, mixing red yeast rice with the mixture, fermenting at 30 DEG C for 65-75 hours, and drying to obtain a pseudo-ginseng processed finished product. The pseudo-ginseng processed finished product has the functions of dissipating blood stasis and stopping bleeding, relieving swelling and pain, activating blood and tonifying qi, strengthening spleen and eliminating food retention, and dissolving turbidity and lowering lipid; the traditional Chinese medicine can treat traumatic injury, blood stasis and blood stasis pain, such as chest pain, headache, dysmenorrhea and other blood stasis states caused by blood stasis, or blood viscosity increase and other blood stasis states.

The invention provides an emergency chest pain treatment resource dynamic scheduling method and system based on multi-objective optimization, relates to the technical field of medical resource optimal scheduling, and aims to solve the problems that in the prior art, dynamic prediction of resource occupation time and systematic modeling of a queue jumping strategy are lacked, resource allocation conflicts are caused to critical patients, and the probability of resource allocation is low. And treatment efficiency and order stability are difficult to balance. Comprising the steps that a resource occupation time prediction model is constructed through DNN, patient features, examination item information and text data containing doctor remarks are collected for training, dynamic optimization is achieved in combination with a multi-target PSO algorithm, and the queue jumping positions of critical patients are dynamically adjusted. According to the method, the waiting time of critical patients is minimized, the disturbance degree of a conventional patient queue is minimized, the order destruction degree of existing medical queues is minimized, the normal examination and treatment order of a hospital is maintained, and efficient utilization and order stability of medical resources are realized.

The invention belongs to the technical field of traditional Chinese medicines, and relates to a traditional Chinese medicine composition for adjuvant treatment of phlegm-heat obstructing lung type advanced non-small cell lung cancer (NCSLC). The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 15-30 parts of rheum officinale, 15-30 parts of fructus trichosanthis, 15-30 parts of fried Chinese waxgourd seeds, 15-30 parts of coix seeds, 15-30 parts of fried fructus aurantii, 15-30 parts of ginger processed cortex magnoliae officinalis, 15-30 parts of fried semen raphani, 10-15 parts of radix curcumae, 10-15 parts of rhizoma curcumae longae, 10-15 parts of oldenlandia diffusa and 10-15 parts of radix ranunculi ternati. The invention further provides a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is used for treating the phlegm-heat obstructing lung type advanced NCSLC, the main symptoms include cough, expectoration, phlegm blood, chest pain, inappetence, nausea and vomiting, constipation and the like, and the traditional Chinese medicine composition can be used for long-term treatment of patients with the advanced NCSLC by being matched with a traditional Chinese medicine preparation for strengthening the body resistance. The traditional Chinese medicine composition has a good curative effect on phlegm-heat obstructing lung type advanced NCSLC, and is reasonable in formula, free of toxic and side effects and safe and reliable in curative effect.

The application discloses a kind of coronary heart disease health education system and method based on augmented reality, it is related to medical health education field.System includes AR device, VR device, depth camera and intelligent terminal, intelligent terminal linkage hospital database, based on patient CT image, clinical diagnosis and so on Medical data generates personalized three-dimensional cardiovascular model;Depth camera collects human skeleton data, after screening optimization by intelligent terminal, transmission to AR device;AR device is completed coordinate system alignment by PnP algorithm, accurately registers model in patient chest cavity and renders, synchronizes to VR device by TCP / UDP hybrid protocol;Response interaction instruction, dynamically demonstrate myocardial ischemia, chest pain diffusion and other pathological evolution process, combined with resource dynamic loading and space anchor point technology guarantee stability.The application realizes doctor-patient AR visual angle sharing and accurate personalized propaganda and education, solves the pain points of traditional propaganda and education abstraction, interaction deficiency and low participation, significantly improves patient cognitive efficiency, and has wide application prospect.

The present invention belongs to a Chinese medicine composition for clinical auxiliary treatment of phlegm and blood stasis syndrome of coronary artery insufficiency and its preparation and specific usage. The technical scheme of the present invention is: 30 parts of Trichosanthes peel, 30 parts of Asarum, 10 parts of Cinnamon bark, 10 parts of Santalum album, 10 parts of Olibanum, and 3 parts of Borneol are ground into fine powder, and vinegar is added to blend into a paste, which is a Chinese medicine patch for treating ischemic angina pectoris. The present invention uses the Chinese medicine composition to apply Xinshu acupoint and Shenmen acupoint in a specific time period to warm and transform phlegm and fluid, promote blood circulation and dredge collaterals, and achieve the purpose of relieving chest pain. The Chinese medicine prepared by the prescription has small toxic and side effects, and is more effective when used in conjunction with the classic acupoint matching method of traditional Chinese medicine, Nazhi method.

The invention provides a traditional Chinese medicine composition for treating myocardial infarction, a medicinal preparation and a preparation method thereof, and belongs to the technical field of medicines. The traditional Chinese medicine composition comprises the following components: astragalus membranaceus, codonopsis pilosula, ligusticum wallichii, salvia miltiorrhiza, lily, lindera aggregata, radix rehmanniae, pseudo-ginseng and rhizoma cyperi. The traditional Chinese medicine composition and the medicinal preparation provided by the invention have the effects of tonifying qi and activating blood, nourishing yin and dredging collaterals, and promoting qi circulation and relieving pain, and can be used for treating qi-yin deficiency and blood stasis syndromes such as myocardial infarction accompanied by shortness of breath and weakness, chest pain such as stabbing, dysphoria and insomnia, dry mouth and constipation.

The invention discloses a high-risk chest pain patient triage identification system based on machine learning, and belongs to the technical field of medical triage, and the system specifically comprises the steps: storing chest pain related keywords and triage indexes in a keyword library, and coding the chest pain related keywords and triage indexes into text feature vectors; the text recognition module collects medical records, traverses text information, marks subjective keywords, and calculates an initial triage level; the image acquisition module collects and preprocesses patient condition images; the text and graph matching module encodes an image into a feature vector, retrieves a nearest text feature vector, and marks a matching keyword; and the triage correction module compares the subjective keyword set with the matching keyword set, determines a final triage grade according to different set relationships, takes an initial grade when the matching keyword set is a subset of the subjective keyword set, takes a matching grade when the matching keyword set is a subset of the subjective keyword set, and comprehensively judges when the matching keyword set and the matching keyword set are intersected or mutually excluded, so that accurate triage of the chest pain patient is realized.

The invention belongs to the technical field of medicine application, and particularly relates to application of Pingxiao tablets in preparation of medicine for treating pulmonary nodules. The invention discloses application of Pingxiao tablets in preparation of a medicine for treating pulmonary nodules. The invention also discloses a combined application of the Pingxiao tablet and the radix bupleuri liver-soothing pill in preparation of medicines for treating pulmonary nodules. A test result shows that the integral points of a Pingxiao tablet treatment group and a Pingxiao tablet and radix bupleuri liver-soothing pill combined treatment group in chest pain, chest distress, shortness of breath, cough and excessive phlegm are lower than those of a control group; the pulmonary nodule size, pulmonary nodule area and pulmonary nodule volume are all smaller than those of a control group, the total effective rate is higher than that of the control group, the pulmonary nodule risk level grading low-risk proportion is higher than that of the control group, the middle-risk and high-risk proportions are both lower than that of the control group, and the adverse reaction incidence rate is lower than that of the control group. Compared with the radix bupleuri liver-soothing pill, the Pingxiao tablet or the Pingxiao tablet and the radix bupleuri liver-soothing pill have a more remarkable clinical curative effect on treating the phlegm-blood stasis type pulmonary nodule.